Prenetics IM8 secures $1B financing from General Catalyst
Prenetics Global Limited announced that its IM8 brand secured $1 billion in growth financing from General Catalyst’s Customer Value Fund. The company raised its full-year 2026 IM8 revenue guidance to $210–220 million, up from $190–210 million, following strong performance. The financing covers up to 70% of marketing spend without equity issuance.
*this image is generated using AI for illustrative purposes only.
Prenetics Global Limited announced that its IM8 brand has secured $1 billion in growth financing from General Catalyst’s Customer Value Fund (CVF). The arrangement provides capital to finance customer acquisition without issuing equity, allowing IM8 to accelerate marketing across its 43 markets while preserving Prenetics’ balance sheet. Prenetics raised its full-year 2026 IM8 revenue guidance to $210–220 million, up from the previous range of $190–210 million, following the brand's strongest monthly revenue performance in June 2026.
Under the terms of the financing, General Catalyst’s Customer Value Fund will finance up to 70% of IM8’s marketing spend on a monthly cohort basis. In return, General Catalyst receives a capped share of income tied to the performance of the financed customer cohorts. Once General Catalyst recovers its investment and the capped return, all subsequent value from those customers accrues permanently to IM8. The structure involves no equity issuance, warrants, or convertible instruments, and is tracked separately for each monthly cohort.
Financial Position and Guidance
Prenetics enters this partnership with approximately $139.7 million in combined cash, financial assets, and escrow holdings as of May 31, 2026. The company also maintains a $40 million share repurchase program announced earlier in 2026. The new financing is expected to support IM8’s growth trajectory, with the brand targeting $300 million in annualized run-rate revenue by year-end 2026 and exceeding $400 million in full-year 2027 revenue.
Key Commercial Terms
| Term | Details |
|---|---|
| Total commitment | $1.0 billion |
| Funded share of marketing spend | Up to 70% of IM8’s marketing spend on a monthly cohort basis |
| General Catalyst return | Capped share of Reference Income from financed cohorts, subject to a fixed multiple on the funding amount |
| Cohort waterfall | Once the capped return is reached, all subsequent value accrues entirely to IM8 |
| Equity issued to General Catalyst | None. No shares, warrants, or convertible instruments are issued |
| Expected accounting | Financial liability on the consolidated balance sheet; return component recognized as interest expense below operating income |
Operational Metrics and Strategy
IM8 has delivered over 50 million servings to date, with approximately 200,000 servings delivered daily and an order placed every 27 seconds. The brand operates as an AI-native organization, using machine learning to optimize marketing and customer retention across 43 markets. Every $1 invested in customer acquisition has returned $1.44 in gross profit, blended across all mature cohorts. The financing will be deployed across digital performance marketing, offline media, ambassador partnerships, and content production.
How will the recognition of the financing return as interest expense impact Prenetics’ adjusted EBITDA margins and net income during the ramp-up period?
What specific metrics or triggers will determine if General Catalyst exercises its option to reduce funding below the 70% threshold for future monthly cohorts?
Can IM8 sustain its current $1.44 gross profit return on customer acquisition as it scales marketing spend aggressively across new and existing markets?
19
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
